Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

July 4, 2025

Study Completion Date

July 4, 2025

Conditions
PsoriasisPruritusDry Skin
Interventions
DEVICE

Dexeryl (RL3020-DP0364)

Product application on body (head excluded)

Trial Locations (1)

80288

RECRUITING

Dermscan Poland, Gdansk

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT06800755 - Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus | Biotech Hunter | Biotech Hunter